Search bioRxiv⌕ Search

Biology subjects

Mullen, R. D.

Publications and source records attributed to Mullen, R. D..

2 recordsLinked to original sources

Distal-less homeobox genes Dlx5/6 regulate Mulllerian duct regression

Dlx5 and Dlx6 encode distal-less homeodomain transcription factors that are present in the genome as a linked pair at a single locus. Dlx5 and Dlx6 have redundant roles in craniofacial, skeletal, and uterine development. Previously, we performed a transcriptome comparison for anti-Mullerian hormone (AMH)-induced genes expressed in the Mullerian duct mesenchyme of male and female mouse embryos. In that study, we found that Dlx5 transcripts were nearly seven-fold higher in males compared to females and Dlx6 transcripts were found only in males, suggesting they may be AMH-induced genes. Therefore, we investigated the role of Dlx5 and Dlx6 during AMH-induced Mullerian duct regression. We found that Dlx5 was detected in the male Mullerian duct mesenchyme from E14.5 to E16.5. In contrast, in female embryos Dlx5 was detected in the Mullerian duct epithelium. Dlx6 expression in Mullerian duct mesenchyme was restricted to males. Dlx6 expression was not detected in female Mullerian duct mesenchyme or epithelium. Genetic experiments showed that AMH signaling is necessary for Dlx5 and Dlx6 expression. Mullerian duct regression was variable in Dlx5 homozygous mutant males at E16.5, ranging from regression like controls to a block in Mullerian duct regression. In E16.5 Dlx6 homozygous mutants, Mullerian duct tissue persisted primarily in the region adjacent to the testes. In Dlx5-6 double homozygous mutant males Mullerian duct regression was also found to be incomplete but more severe than either single mutant. These studies suggest that Dlx5 and Dlx6 act redundantly to mediate AMH-induced Mullerian duct regression during male differentiation.

developmental biology↗

CreLite: An Optogenetically Controlled Cre/loxP System Using Red Light

Precise manipulation of gene expression with temporal and spatial control is essential for functional studies and the determination of cell lineage relationships in complex biological systems. The Cre-loxP system is commonly used for gene manipulation at desired times and places. However, specificity is dependent on the availability of tissue- or cell-specific regulatory elements used in combination with Cre or CreER (tamoxifen-inducible). Here we present CreLite, an optogenetically-controlled Cre system using red light in developing zebrafish embryos. Cre activity is disabled by splitting Cre and fusing the inactive halves with the Arabidopsis thaliana red light-inducible binding partners, PhyB and PIF6. In addition, PhyB-PIF6 binding requires phycocyanobilin (PCB), providing an additional layer of control. Upon exposure to red light (660 nm) illumination, the PhyB-CreC and PIF6-CreN fusion proteins come together in the presence of PCB to restore Cre activity. Red-light exposure of transgenic zebrafish embryos harboring a Cre-dependent multi-color fluorescent protein reporter (ubi:zebrabow) injected with CreLite mRNAs and PCB, resulted in Cre activity as measured by the generation of multi-spectral cell labeling in various tissues, including heart, skeletal muscle and epithelium. We show that CreLite can be used for gene manipulations in whole embryos or small groups of cells at different stages of development. CreLite provides a novel optogenetic tool for precise temporal and spatial control of gene expression in zebrafish embryos that may also be useful in cell culture, ex vivo organ culture, and other animal models for developmental biology studies.

molecular biology↗